US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 7.995
  • -0.025-0.31%
Trading May 10 13:09 ET
923.62MMarket Cap-2115P/E (TTM)

Arcutis Biotherapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Apr 30, 2024

Based on 6 analysts giving stock ratings to Arcutis Biotherapeutics in the past 3 months

Buy

  • Buy

    66.67%

  • Hold

    33.33%

  • Sell

    0.00%

Price Target

Updated: Apr 30, 2024

The average Arcutis Biotherapeutics stock price target is 16.40 with a max estimate of 20.00 and a min estimate of 11.00

Review Arcutis Biotherapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Apr 30, 2024

Buy

  • Buy

    66.67%

  • Hold

    33.33%

  • Sell

    0.00%

Price Target

Updated: Apr 30, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg